Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

University of Florida Phase 3 Trial on CoQ10, for kids 12 to 17

Discussion in 'Active Clinical Studies' started by *GG*, Oct 20, 2010.

  1. *GG*

    *GG* Senior Member

    Messages:
    5,720
    Likes:
    4,004
    Concord, NH
    The University of Florida is continuing to recruit patients for a clinical trial to investigate the safety and effectiveness of Coenzyme Q10 (CoQ10) as a treatment for children with specific mitochondrial diseases.

    CoQ10 is a mitochondrial cofactor and antioxidant in the process that cells use to convert food and oxygen into energy.

    To be considered for the trial, patients must be 12 months to 17 years of age and have a biochemical or molecular diagnosis of a deficiency of complex I, III or IV of the respiratory chain.

    For additional information contact Courtney Yates, RN, at Courtney.Yates@medicine.ufl.edu or at 352-273-9016.
     

See more popular forum discussions.

Share This Page